Cannabis Use Disorder Market is segmented By Treatment (Pharmacotherapy (Synthetic cannabinoids, CB1...
Market Size in USD Bn
CAGR9.5%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 9.5% |
Market Concentration | Medium |
Major Players | Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, Zynerba Pharmaceuticals and Among Others |
The cannabis use disorder market is estimated to be valued at USD 1.80 Bn in 2025 and is expected to reach USD 3.40 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032. With increasing legalization of cannabis for medical and recreational purposes, more people are gaining access and risk developing cannabis use disorder. This growing acceptance and access to cannabis is expected to significantly drive the growth of the cannabis use disorder market over the forecast period.